2025
Optimizing Psychological Health Across the Perinatal Period: An Update on Maternal Cardiovascular Health: A Scientific Statement From the American Heart Association
Sharma G, Gaffey A, Hameed A, Kasparian N, Mauricio R, Marsh E, Beck D, Skowronski J, Wolfe D, Levine G, Research T. Optimizing Psychological Health Across the Perinatal Period: An Update on Maternal Cardiovascular Health: A Scientific Statement From the American Heart Association. Journal Of The American Heart Association 2025, 14: e041369. PMID: 39996493, PMCID: PMC12132617, DOI: 10.1161/jaha.125.041369.Peer-Reviewed Original ResearchConceptsMaternal cardiovascular healthPsychological healthCardiovascular healthAmerican Heart AssociationPerinatal periodCare delivery modelsMaternal psychological healthScientific statementPsychological health carePostpartum follow-upHeart AssociationPsychological health conditionsAssociated with adverse pregnancy outcomesCardiovascular outcomesMaternal mortalityAdverse pregnancy outcomesHealth careDelivery modelsHealth conditionsLong-term cardiovascular outcomesHealthStakeholder partnersOffspring neurodevelopmentPregnancy outcomesCare
2022
Gender Differences in Guideline-Directed Medical Therapy for Cardiovascular Disease Among Young Veterans
Dhruva SS, Dziura J, Bathulapalli H, Rosman L, Gaffey AE, Davis MB, Brandt CA, Haskell SG. Gender Differences in Guideline-Directed Medical Therapy for Cardiovascular Disease Among Young Veterans. Journal Of General Internal Medicine 2022, 37: 806-815. PMID: 36042086, PMCID: PMC9481764, DOI: 10.1007/s11606-022-07595-1.Peer-Reviewed Original ResearchConceptsGuideline-directed medical therapyIncident coronary artery diseaseCoronary artery diseaseHeart failureMedical therapyCardiovascular diseaseWomen veteransDiagnosis of HFAldosterone system inhibitorsIncident heart failureAdverse cardiovascular outcomesClinical practice guidelinesRisk of mortalityLevel of evidenceYounger women veteransHF medicationsMultiple pharmacotherapiesAntiplatelet therapyCardiovascular outcomesYounger average ageArtery diseaseCVD careGuideline recommendationsSystem inhibitorsAdverse outcomesDepressive Symptoms and Incident Heart Failure in the Jackson Heart Study: Differential Risk Among Black Men and Women
Gaffey AE, Cavanagh CE, Rosman L, Wang K, Deng Y, Sims M, O’Brien E, Chamberlain AM, Mentz RJ, Glover LM, Burg MM. Depressive Symptoms and Incident Heart Failure in the Jackson Heart Study: Differential Risk Among Black Men and Women. Journal Of The American Heart Association 2022, 11: e022514. PMID: 35191315, PMCID: PMC9075063, DOI: 10.1161/jaha.121.022514.Peer-Reviewed Original ResearchConceptsIncident heart failureHigher depressive symptomsHF risk factorsHeart failureDepressive symptomsCause mortalityGreater riskLifestyle factorsRisk factorsCases of HFHistory of HFJackson Heart Study participantsSignificant depressive symptomsBaseline depressive symptomsJackson Heart StudyProportional hazards modelSex-specific associationsSex-specific managementCardiovascular outcomesUnadjusted associationsUnadjusted modelsHeart StudyHazards modelSymptomsStudy participants
2020
Chapter 4 Intervention research on therapies that aim to treat depression and cardiovascular disease
Cavanagh C, Gaffey A, Rosman L, Burg M. Chapter 4 Intervention research on therapies that aim to treat depression and cardiovascular disease. 2020, 61-84. DOI: 10.1016/b978-0-12-815015-3.00004-0.Peer-Reviewed Original ResearchCardiovascular outcomesPharmacotherapy interventionsClinical trialsCardiovascular diseaseFuture clinical trialsTreatment of depressionComplexity of depressionClinical trial literatureDepression remissionShort followClinical syndromeCardiac populationDepression severityTrial literatureMedical consequencesPsychological interventionsDepressionTreatment fidelityTrialsInterventionPatientsDiseaseIntervention researchOutcomesTreatment
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply